Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Public ClinicalTrials.gov record NCT01461538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-label Study of Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, multicenter, phase 2 clinical trial to evaluate the antitumor activity of brentuximab vedotin as a single agent in patients with CD30-positive nonlymphomatous malignancies.
Study identification
- NCT ID
- NCT01461538
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2011 (Type not available)
- Primary completion
- Dec 2014 (Actual)
- Completion
- Dec 2014 (Actual)
- Last update posted
- Mar 4, 2016
2011 – 2014
United States locations
- U.S. sites
- 29
- U.S. states
- 14
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294-3300 | — |
| City of Hope | Duarte | California | 91010-3000 | — |
| PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists | Oxnard | California | 93030 | — |
| Rocky Mountain Cancer Centers - Aurora | Aurora | Colorado | 80012 | — |
| Mayo Clinic Cancer Center | Jacksonville | Florida | 32224 | — |
| Ocala Oncology Center | Ocala | Florida | 34471 | — |
| Indiana University Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Minnesota Oncology Hematology P.A. | Minneapolis | Minnesota | 55404 | — |
| New York Oncology Hematology, P.C. | Albany | New York | 12206 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106-5055 | — |
| Willamette Valley Cancer and Research / USOR | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists, P.C. | Tulatin | Oregon | 97062 | — |
| St. Francis Hospital | Greenville | South Carolina | 29605 | — |
| Texas Oncology - Bedford | Bedford | Texas | 76022 | — |
| Texas Oncology - Medical City Dallas | Dallas | Texas | 75230 | — |
| Texas Oncology - Dallas Presbyterian | Dallas | Texas | 75231 | — |
| Texas Oncology Denton South | Denton | Texas | 76210 | — |
| Texas Oncology - Fort Worth 12th Avenue | Fort Worth | Texas | 76104 | — |
| MD Anderson Cancer Center / University of Texas | Houston | Texas | 77030-4003 | — |
| MD Anderson Cancer Center Leukemia Group | Houston | Texas | 77030 | — |
| Texas Oncology - Central Austin Cancer Center | Round Rock | Texas | 78731 | — |
| Cancer Centers of South Texas - HOAST | San Antonio | Texas | 78229 | — |
| Texas Oncology - Waco | Waco | Texas | 76712 | — |
| Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care | Blacksburg | Virginia | 24060 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | — |
| Puget Sound Cancer Centers | Edmonds | Washington | 98026 | — |
| Cancer Care Northwest | Spokane Valley | Washington | 99216 | — |
| Yakima Valley Memorial Hospital / North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01461538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2016 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01461538 live on ClinicalTrials.gov.